Viewing Study NCT02158559


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-02-23 @ 1:53 PM
Study NCT ID: NCT02158559
Status: UNKNOWN
Last Update Posted: 2014-06-09
First Post: 2014-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
Sponsor: Beijing Bozhiyin T&S Co., Ltd.
Organization:

Study Overview

Official Title: A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI(ST- Elevation Myocardical Infarction) After the PTCA Surgery.
Status: UNKNOWN
Status Verified Date: 2014-06
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Danhong
Brief Summary: This study focused on the effect of Danhong injection on microcirculation in the treatment of patients with STEMI(ST-elevation myocardical infarction) after the PTCA surgery.
Detailed Description: Research Topic.

* A randomized, double-blind, placebo-controlled, multi-center clinical trial of the effect of Danhong Injection on microcirculation in the treatment of patients with STEMI(ST- elevation myocardical infarction) after the PTCA surgery.

Research Purpose.

* This study focused on the effect of Danhong injection on microcirculation in the treatment of patients with STEMI(ST-elevation myocardical infarction) after the PTCA surgery.

Research design.

* A randomized, double-blind, placebo-controlled, multi-center clinical trial.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: